BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 26, 2018
View Archived Issues
Ribomic submits IND for anti-FGF-2 candidate
Read More
Phase III EASE-2 and EASE-3 trials of empagliflozin in type 1 diabetes meet primary endpoint
Read More
Aerpio and Gossamer Bio enter exclusive license agreement for AKB-4924
Read More
Biktarvy approved in Europe for the treatment of HIV-1 infection
Read More
Phase Ib trial results for enzalutamide/CC-115 for metastatic castration-resistant prostate cancer
Read More
Aurinia expands voclosporin clinical development program
Read More
EMA validates Giapreza MAA
Read More
Pivotal phase III study of Qzytir in acute urticaria meets key endpoints
Read More
Preliminary results of phase II study of entinostat/pembrolizumab in MSS colorectal cancer
Read More
FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome
Read More
FDA grants priority review to baloxavir marboxil NDA for influenza
Read More
Clinuvel files NDA for Scenesse for erythropoietic protoporphyria
Read More
ContraVir doses first subject in first-in-human study of CRV-431
Read More
Sophiris reports interim data from phase IIb study of topsalysin for prostate cancer
Read More
Cerenis completes enrollment in TARGET study of CER-001 in esophageal cancer
Read More
Pulmatrix reports topline results from phase I/Ib study of Pulmazole
Read More
AbbVie and Calibr establish T-cell therapy collaboration for cancer
Read More
FDA grants priority review to sNDA for Imbruvica with rituximab in Waldenstrom's macroglobulinemia
Read More
University of KwaZulu-Natal patents isatin derivatives
Read More
Universitaet Hamburg divulges nucleoside triphosphate prodrug antivirals
Read More
Roche, Genentech describe RIP-1 inhibitors
Read More
Merck & Co. presents HIV integrase inhibitors
Read More
EPZ-011989 demonstrates promising antitumor activity in preclinical models of epithelioid sarcoma
Read More